| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
MEDJET Assistance is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Central Michigan Community Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Central Michigan Community Hospital is based in Mount Pleasant, MI. You can find more information on Central Michigan Community Hospital at www.cmch.org
Group Health Plan is a West Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SCR Medical Transportation is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.